How Safe Are mRNA Vaccines in Comparison with Traditional Vaccines in Terms of Death/severe Side Effects per 100K Recipients?

The landscape of vaccination has shifted significantly with the advent of mRNA vaccines, such as those produced by Moderna and Pfizer. These vaccines have garnered widespread attention and administration, especially after the global pandemic. However, the question of safety remains a critical area of focus, prompting a detailed analysis of the mortality and severe side effects comparison between mRNA and traditional vaccines.

The FDA meeting on September 17, 2021, highlighted some compelling data regarding booster shots. While these data may present interesting insights, they also raised concerns that align with many individuals' worries. It is important to recognize that making an informed decision about vaccination should be a personalized process, involving consultation with a healthcare provider who can review your individual health status.

The Compelling Data from the FDA Meeting

The September 17, 2021, FDA meeting discussed the parameters behind approving booster shots. This meeting provided some of the information that has aligned with concerns about the vaccine's safety, specifically regarding long-term impacts and individual health considerations. Individuals are encouraged to consult with doctors (and possibly a primary care physician) to make informed decisions based on a comprehensive health evaluation. It is important to conduct your own research and collaborate with a medical professional to understand the potential risks and benefits.

Evaluating Safety: A Closer Look

Comparative Safety

According to recent data, the risk of severe symptoms from the virus, without any vaccination, is 1 in 6. On the other hand, with the mRNA vaccines, the risk of developing severe symptoms decreases to 0.01. This stark difference underscores the potential protective effects of these vaccines. However, it is essential to critically evaluate the broader implications of vaccination, including the potential risks and side effects.

Side Effects and Mortality

VAERS (Vaccine Adverse Event Reporting System) currently reports about 7,200 deaths attributed to the vaccine, although this number has fluctuated and been revised multiple times for various undisclosed reasons. Prior to such revisions, this number was as high as 12,500. These revisions, while necessary, have added to the uncertainty surrounding the vaccine's safety. The risk of myocarditis among young males ranges from approximately 1 in 6,200. Other side effects, such as paralysis and rash, have also been documented in the VAERS reports.

While these side effects are concerning and not to be taken lightly, they are also not as catastrophic as they may seem. According to the CDC, for individuals under 75 years old, generally healthy, and not obese, the survival rate is 99.9% without vaccination. This statistic highlights the stark difference in risk between being vaccinated and not being vaccinated, but it does not dismiss the need for caution.

Comparative Analysis with Traditional Vaccines

When comparing mRNA vaccines to traditional vaccines, traditional vaccines have a long history of development, testing, and safety records. These vaccines often use methodologies such as inactivated viruses, weakened viruses, or subunit components, reducing the risk of severe side effects. On the other hand, mRNA vaccines are relatively new; this lack of history may contribute to some hesitancy among the public and healthcare providers.

In the context of death rates and severe side effects per 100,000 recipients, it is important to consider the data from both types of vaccines. Traditional vaccines generally have lower rates of severe side effects, but this does not mean that they are completely risk-free. Each type of vaccine has its own set of potential side effects and risks, which should be weighed against their benefits.

Conclusion

The question of whether mRNA vaccines are sufficiently safe remains a point of contention. While the data suggest that vaccination offers significant protection against severe symptoms and death, individual safety concerns persist. It is imperative for individuals to consult with healthcare professionals to understand their unique health circumstances and to make informed decisions. The balance between the risks and benefits of vaccination is a personal one, and only the individual can ultimately decide what is best for them.

Key Takeaways:

The risk of severe symptoms from the virus without vaccination is 1 in 6. The risk of developing severe symptoms with mRNA vaccines is 0.01. VAERS reports about 7,200 deaths attributed to the vaccine, but this number has fluctuated and been revised without explanation. The risk of myocarditis among young males ranges from approximately 1 in 6,200. The survival rate for generally healthy adults under 75 with obesity is 99.9% without vaccination.

Ultimately, the decision to vaccinate should be a personalized one, based on an individual's health status and a thorough discussion with a healthcare provider. The ongoing reassessment and revision of vaccine safety data underscore the complexity of this issue and the need for continued vigilance and transparency.